This is particularly concerning for menopausal women, who are already at risk for muscle loss (sarcopenia) due to aging and lower estrogen
Use Multiboost for strategic supplementation of trace minerals at times of increased requirements
Accessed on May 14, 2025 at Bydureon Bcise [package insert]
Wegovy oral (semaglutide pill) , FDA-approved for weight loss in late 2025 and launched January 2026, runs $189$299/mo through manufacturer direct programs and select telehealth routes
As well, in real-world scenarios, such as described by Brindisi et al, it is mentioned a reduction in pleasure and taste perception in overweight and people with obesity with poor type 2 diabetes control, probably by lowering the detection threshold of sweet flavors, becoming more sensitive to them, resulting in aversion for this flavor (175)
Whitens & brightens